Latest news
CellCarta adds Tempus to companion diagnostic commercialisation network - Manufacturing ChemistManufacturing Chemist · Fri, 07 Aug 2026 11:00:39 GMTSOPHiA GENETICS and AstraZeneca Collaborate to Develop Oncology Companion Diagnostics - Clinical Lab ProductsClinical Lab Products · Wed, 05 Aug 2026 20:52:25 GMTLabcorp Launches FDA-Approved IHC Companion Diagnostic for Prostate Cancer - Clinical Lab ProductsClinical Lab Products · Wed, 05 Aug 2026 20:52:25 GMTSophia Genetics SA and AstraZeneca Enter Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies - marketscreener.commarketscreener.com · Tue, 04 Aug 2026 17:52:13 GMTSOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies - PR NewswirePR Newswire · Tue, 04 Aug 2026 10:15:00 GMTSOPHiA GENETICS Plans Tests for Solid Tumors, Blood Cancer - Stock TitanStock Titan · Tue, 04 Aug 2026 10:15:00 GMT